dilluns, 11 d’agost del 2014

Medtronic-Covidien merger means tax hit for all stockholders, including execs




The terms of Medtronic's unusual $43 billion acquisition of Covidien means that all MDT shareholders are subject to paying a capital gains tax, including executives and board members.





Medtronic-Covidien merger means tax hit for all stockholders, including execs



read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/VdxJb0

Cap comentari:

Publica un comentari a l'entrada